Editorial

Split Viewer

Korean J Hematol 2011; 46(2):

Published online June 21, 2011

https://doi.org/10.5045/kjh.2011.46.2.60

© The Korean Society of Hematology

The next step for Burkitt lymphoma

Bin Cho, M.D.

Department of Pediatrics, The Catholic University of Korea, School of Medicine, Seoul, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

REFERENCES

  1. de Leval, L, Hasserjian, RP. Diffuse large B-cell lymphomas and burkitt lymphoma. Hematol Oncol Clin North Am, 2009;23;791-827.
    Pubmed
  2. Kenkre, VP, Stock, W. Burkitt lymphoma/leukemia: improving prognosis. Clin Lymphoma Myeloma, 2009;9;S231-S238.
    Pubmed
  3. Patte, C. Treatment of mature B-ALL and high grade B-NHL in children. Best Pract Res Clin Haematol, 2002;15;695-711.
    Pubmed
  4. Park, ES, Kim, H, Lee, JW, et al. Treatment outcomes in children with burkitt lymphoma and L3 acute lymphoblastic leukemia treated using the lymphoma malignancy B protocol at a single institution. Korean J Hematol, 2011;46;96-102.
  5. Patte, C, Auperin, A, Michon, J, et al. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood, 2001;97;3370-3379.
    Pubmed
  6. Poirel, HA, Cairo, MS, Heerema, NA, et al. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Leukemia, 2009;23;323-331.
    Pubmed
  7. Swerdlow SH, Campo E, Harris NL. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press.
  8. Klapproth, K, Wirth, T. Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol, 2010;149;484-497.
    Pubmed

Article

Editorial

Korean J Hematol 2011; 46(2): 60-61

Published online June 21, 2011 https://doi.org/10.5045/kjh.2011.46.2.60

Copyright © The Korean Society of Hematology.

The next step for Burkitt lymphoma

Bin Cho, M.D.

Department of Pediatrics, The Catholic University of Korea, School of Medicine, Seoul, Korea.

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

    References

    1. de Leval, L, Hasserjian, RP. Diffuse large B-cell lymphomas and burkitt lymphoma. Hematol Oncol Clin North Am, 2009;23;791-827.
      Pubmed
    2. Kenkre, VP, Stock, W. Burkitt lymphoma/leukemia: improving prognosis. Clin Lymphoma Myeloma, 2009;9;S231-S238.
      Pubmed
    3. Patte, C. Treatment of mature B-ALL and high grade B-NHL in children. Best Pract Res Clin Haematol, 2002;15;695-711.
      Pubmed
    4. Park, ES, Kim, H, Lee, JW, et al. Treatment outcomes in children with burkitt lymphoma and L3 acute lymphoblastic leukemia treated using the lymphoma malignancy B protocol at a single institution. Korean J Hematol, 2011;46;96-102.
    5. Patte, C, Auperin, A, Michon, J, et al. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia. Blood, 2001;97;3370-3379.
      Pubmed
    6. Poirel, HA, Cairo, MS, Heerema, NA, et al. Specific cytogenetic abnormalities are associated with a significantly inferior outcome in children and adolescents with mature B-cell non-Hodgkin's lymphoma: results of the FAB/LMB 96 international study. Leukemia, 2009;23;323-331.
      Pubmed
    7. Swerdlow SH, Campo E, Harris NL. World Health Organization classification of tumours of haematopoietic and lymphoid tissues. Lyon, France: IARC Press.
    8. Klapproth, K, Wirth, T. Advances in the understanding of MYC-induced lymphomagenesis. Br J Haematol, 2010;149;484-497.
      Pubmed
    Blood Res
    Volume 59 2024

    Stats or Metrics

    Share this article on

    • line

    Blood Research

    pISSN 2287-979X
    eISSN 2288-0011
    qr-code Download